KMDA (Kamada) FCF Yield % : 9.67 (As of Dec. 11, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Kamada FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kamada's Trailing 12-Month Free Cash Flow is $31.8 Mil, and Market Cap is $338.8 Mil. Therefore, Kamada's FCF Yield % for today is 9.67%.

The historical rank and industry rank for Kamada's FCF Yield % or its related term are showing as below:

KMDA' s FCF Yield % Range Over the Past 10 Years
Min: -12.16 Med: 1.77 Max: 12.83
Current: 9.67

During the past 13 years, the highest FCF Yield % of Kamada was 12.83%. The lowest was -12.16%. And the median was 1.77%.

KMDA's FCF Yield % is ranked better than
89.04% of 1040 companies
in the Drug Manufacturers industry
Industry Median: 0.135 vs KMDA: 9.67

Kamada's FCF Margin % for the quarter that ended in Sep. 2024 was 48.13%.

Kamada FCF Yield % Historical Data

The historical data trend for Kamada's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kamada FCF Yield % Chart

Kamada Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

9.17

4.70

-4.26

13.80

-0.44

Kamada Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															-1.05	2.77	-2.06	15.36	26.03

Competitive Comparison of Kamada's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kamada's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kamada's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kamada's FCF Yield % falls into.

Kamada FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kamada's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.535	/	351.77454
	=	-0.44%

Kamada's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	20.089	*	4	/	308.733651
	=	26.03%

Kamada FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kamada FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kamada's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kamada Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (NAS:KMDA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

KMDA:Israel

Address

2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402

Website

https://www.kamada.com

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.